Wednesday, April 06, 2022 3:06:14 PM
That exactly the point
"We know the answer to the buyback, it never happened."
If they did not follow up on this how can you blieve they will follow up on an unknown acquisition.
"For what products exactly ? "
A year ago "SOHM has received a mandate from one of its customers for the development, manufacturing, and supply of seven of the customer’s new products. These products are human prescription products and are in use in skin care and acne care. "
"have you asked them ? "
Shouldn't have to it is called marketing.
"We know the answer to the buyback, it never happened."
If they did not follow up on this how can you blieve they will follow up on an unknown acquisition.
"For what products exactly ? "
A year ago "SOHM has received a mandate from one of its customers for the development, manufacturing, and supply of seven of the customer’s new products. These products are human prescription products and are in use in skin care and acne care. "
"have you asked them ? "
Shouldn't have to it is called marketing.
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
